COVID-19 vaccination and SARS-CoV-2 infection in early pregnancy and the risk of major congenital anomalies: a national population-based cohort study
Preprint
- 6 October 2022
- preprint
- Published by Springer Nature in Research Square
Abstract
Evidence on associations between COVID-19 vaccination or SARS-CoV-2 infection and the risk of congenital anomalies is limited. We conducted a national, population-based, matched cohort study to estimate the association between COVID-19 vaccination and, separately, SARS-CoV-2 infection between six weeks pre-conception and 19 weeks and six days gestation and the risk of [1] any congenital anomaly and; [2] non-genetic anomalies. Mothers vaccinated in this pregnancy exposure period mostly received an mRNA vaccine (73.7% Pfizer-BioNTech BNT162b2 and 7.9% Moderna mRNA-1273). Of the 6,731 babies whose mothers were vaccinated in the pregnancy exposure period, 153 had any congenital anomaly and 120 had a non-genetic anomaly. Primary analyses found no association between vaccination and any anomaly (adjusted Odds Ratio [aOR] = 1.01, 95% Confidence Interval [CI] = 0.83–1.24) or non-genetic anomalies (aOR = 1.00, 95% CI = 0.81–1.22). Primary analyses also found no association between SARS-CoV-2 infection and any anomaly (aOR = 1.02, 95% CI = 0.66–1.60) or non-genetic anomalies (aOR = 0.94, 95% CI = 0.57–1.54). Findings were robust to sensitivity analyses. These data provide reassurance on the safety of vaccination, in particular mRNA vaccines, just before or in early pregnancy.Keywords
All Related Versions
- Version 1, 2022-10-06, Research Square
- Published version: Nature Communications, 14 (1), 1.
This publication has 22 references indexed in Scilit:
- Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 InfectionJAMA Pediatrics, 2021
- Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant PersonsNew England Journal of Medicine, 2021
- COVID‐19 vaccine acceptance in pregnant womenInternational Journal of Gynecology & Obstetrics, 2021
- Prevalence, clinical features, and outcomes of SARS-CoV-2 infection in pregnant women with or without mild/moderate symptoms: Results from universal screening in a tertiary care center in Mexico City, MexicoPLOS ONE, 2021
- COVID-19 in Pregnancy in Scotland (COPS): protocol for an observational study using linked Scottish national dataBMJ Open, 2020
- Pregnancy Outcomes Among Women With and Without Severe Acute Respiratory Syndrome Coronavirus 2 InfectionJAMA Network Open, 2020
- Analysis of SARS-CoV-2 vertical transmission during pregnancyNature Communications, 2020
- Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysisBMJ, 2020
- Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety dataVaccine, 2016
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007